Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV- infected long-term nonprogressors

Journal of Clinical Investigation

Volumn 100, Issue 6, 1997, Pages 1581-1589

  Cohen, Oren J ^a   Vaccarezza, Mauro ^a   Lam, Gordon K ^a   Baird, Barbara F ^a   Wildt, Kathryn ^a   Murphy, Philip M ^a   Zimmerman, Peter A ^a   Nutman, Thomas B ^a   Fox, Cecil H ^b   Hoover, Shelley ^b   Adelsberger, Joseph ^c   Baseler, Michael ^c   Arthos, James ^a   Davey Jr , Richard T ^a   Dewar, Robin L ^d   Metcalf, Julia ^a   Schwartzentruber, Douglas J ^e   Orenstein, Jan M ^f   Buchbinder, Susan ^g   Saah, Alfred J ^h   Detels, Roger ⁱ   Phair, John ^j   Rinaldo, Charles ^k   Margolick, Joseph B ^h   Pantaleo, Giuseppe ^l   Fauci, Anthony S ^a   more..

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b Molecular Histology Labs   (United States)

^c SAIC FREDERICK INC   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^g AIDS Office San Francisco   (United States)

^h JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j NORTHWESTERN UNIVERSITY   (United States)

^k UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^l UNIVERSITY OF LAUSANNE   (Switzerland)

more..

Author keywords

CC chemokine receptor 5; Disease progression; HIV 1; Lymph nodes; Polymorphism

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DNA POLYMORPHISM; HETEROZYGOSITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0030867550     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119682     Document Type: Article

References (61)

1. Fauci, A.S. 1993. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science (Wash. DC). 262:1011-1018.
2. Fauci, A.S. 1996. Host factors and the pathogenesis of HIV-mdueed disease. Nature (Lond.). 384:529-534.
3. Lifson, A.R., S.P. Buchbinder, and H.W. Sheppard. 1991. Long-term human immunodeficiency virus infection in asymptomatic homosexual and bisexual men with normal CD4+ lymphocyte counts: immunologic and virologic characteristics. J. Infect. Dis. 163:959-965.
4. Sheppard, H.W., W. Lang, M.S. Ascher, E. Vittinghoff, and W. Winkelstein. 1993. The characterization of non-progressors: long-term HIV-1 infection with stable CD4+ T-cell levels. AIDS (Lond.). 7:1159-1166.
5. Easterbrook, P.J. 1994. Non-progression in HIV infection. AIDS (Lond.). 8:1179-1182.
6. Pantaleo, G., S. Menzo, M. Vaccarezza, C. Graziosi, O.J. Cohen, J.F. Demarest, D. Montefiori, J.M. Orenstein, C. Fox, L.K. Schrager, et al. 1995. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N. Engl. J. Med. 332:209-216.
7. Cao, Y., L. Qin, L. Zhang, J. Safrit, and D.D. Ho. 1995. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N. Engl. J. Med. 332:201-208.
8. Montefiori, D., G. Pantaleo, L.M. Fink, J.T. Zhou, J.Y. Zhou, M. Bilska, G.D. Miralles, and A.S. Fauci. 1996. Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors. J. Infect. Dis. 173:60-67.
9. Kirchhoff, F., T.C. Greenough, D.B. Brettler, J.L. Sullivan, and R.C. Desrosiers. 1995. Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N. Engl. J. Med. 332:228-232.
10. Iversen, A.K.N., E.G., Shpaer, A.G. Rodrigo, M.S. Hirsch, B.D. Walker, H.W. Sheppard, T.C. Merigan, and J.I. Mullins. 1995. Persistence of attenuated rev genes in a human immunodeficiency virus type 1-infected asymptomatic individual. J. Virol. 69:5743-5753.
11. Deacon, N.J., A. Tsykin , A. Solomon, K. Smith, M. Ludford-Menting, D.J. Hooker, D.A. McPhee, A.L. Greenway, A. Ellett, C. Chatfield, et al. 1995. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science (Lond.). 270:988-991.
12. Huang, Y., L. Zhang, and D.D. Ho. 1995. Characterization of nef sequences in long-term survivors of human immunodeficiency virus type 1 infection. J. Virol. 69:93-100.
13. Nowak, M.A., R.M. May, R.E. Phillips, S. Rowland-Jones, D.G. Lalloo, S. McAdam, P. Klenerman, B. Koppe, K. Sigmund, C.R.M. Bangham, and A.J. McMichael. 1995. Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature (Lond.). 375:606-611.
14. Wolinsky, S., B.T.M. Korber, A.U. Neumann, M. Daniels, K.J. Kunstman, A.J. Whetsell, M.R. Furtado, Y. Cao, D.D. Ho, J.T. Safrit, and R.A. Koup. 1996. Adaptive evolution of human immunodeficiency virus type 1 during the natural course of infection. Science (Wash, DC). 272:537-542.
15. Deng, H., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. DiMarzio, S. Marmon, R.E. Sutton, C.M. Hill, et al. 1996. Identification of a major co-receptor for primary isolates of HIV-I. Nature (Lond.). 381:661-666.
16. Dragic, T., V. Litwin, G.P. Allaway, S.R. Martin, Y. Huang, K.A. Nagashima, C. Cayanan, P.J. Maddon, R.A. Koup, J.P. Moore, and W.A. Paxton. 1996. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature (Lond.). 381:667-673.
17. Alkhatib, G., C. Combadiere, C.C. Broder, Y. Feng, P.E. Kennedy, P.M. Murphy, and E.A. Berger. 1996. CC CKR5: a RANTES, MIP-1α, MIP-1β receptor as a fusion colactor for maerophage-tropic HlV-I. Science (Wash. DC). 272:1955-1958.
18. Choc, H., M. Farzan, Y. Sun, N. Sullivan, B. Rollins, P.D. Ponath, L. Wu, C.R. MacKay, G. LaRosa, W. Newman. et al. 1996. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell. 85:1135-1148.
19. Doranz, B., J. Rucker, Y. Yi, R.J. Smyth, M. Samson, S.C. Peiper, M. Parmentier, R.G. Collman, and R.W. Doms. 1996. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5 CKR-3, and CKR-2b as fusion cofactors. Cell. 85:1149-1158.
20. Zhu, T., H. Mo, N. Wang, D.S. Nam, Y. Cao, R.A. Koup, and D.D. Ho, 1993. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science (Wash. DC). 261:1179-1181.
21. van't Wout, A.B., N.A. Kootstra, G.A. Mulder-Kampinga, N. Albrechtvan Lent, H.J. Scherpbier, J. Veenstra, K. Boer, R.A. Coutinho, F. Miedema, and H. Schuitemaker. 1994. Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission. J. Clin. Invest. 94:2060-2067.
22. Kinter, A.L., M. Ostrowski, D. Goletti, A. Oliva, D. Weissman, K. Gantt, E. Hardy, R. Jackson, L. Ehler, and A.S. Fauci. 1996. HIV replication in CD4+ T cells of HIV-infected individuals is regulated by a balance between the viral suppressive effects of endogenous beta-chemokines and the viral inductive effects of other endogenous cylokines. Proc. Natl. Acad. Sci. USA. 93:14076-14081.
23. Cocchi, F., A.L. DeVico, A. Garzino-Demo, S.K. Arya, R.C. Gallo, and P. Lusso. 1995. Identification of RANTES, MIP-1α, and MIP-1β as the major HIV suppressive factors produced by CD8+ T cells. Science (Wash. DC). 270: 1811-1815.
24. Paxton, W.A., S.R. Martin, D. Tse, T.R. O'Brien, J. Skurnick, N.L. VanDevanter, N. Padian, J.F. Braun, D.P. Kotler, S.M. Wolinsky, and R.A. Koup. 1996. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposures. Nat. Med. 2:412-417.
25. Liu, R., W.A. Paxton, S. Choe, D. Ceradini, S.R. Martin, R. Horuk, M.E. MacDonald, H. Stuhlmann, R.A. Koup, and N.R. Landau. 1996. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell. 86:367-377.
26. Samson, M., F. Libert, B.J. Doranz, J. Rucker, C. Liesnard, C.M. Farber, S. Saragosti, C. Laouméroulie, J. Cognaux, C. Forceille, et al. 1996. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR5 chemokine receptor gene. Nature (Lond.). 382:722-725.
27. Dean, M., M. Carrington, C. Winkler, G.A. Huttley, M.W. Smith, R. Allikmets, J.J. Goedert, S.P. Buchbinder, E. Vittinghoff, E. Gomperts, et al. 1996. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study. San Francisco City Cohort, ALIVE Study. Science (Wash. DC). 273:1856-1862.
28. Huang, Y., W.A. Paxton, S.M. Wolinsky, A.D. Neumann, L. Zhang, T. He, S. Kang, D. Ceradini, Z. Jin, K. Yazdanbakhsh, et al. 1996. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat. Med. 2:1240-1243.
29. Zimmerman, P.A., A. Buckler-White, G. Alkhatib, T. Spalding, J. Kubofcik, C. Combadiere, D. Weissman, O. Cohen, A. Rubbert, G. Lam, et al. 1997. Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial backgrounds and quantified risks. Mol. Med. (Camb.). 3: 22-35.
30. Biti, R., R. French, J. Young, B. Bennetts, G. Stewart, and T. Liang, 1997. HIV-1 infection in an individual homozygous for the CCR5 deletion allele. Nat. Med. 3:252-253.
31. O'Brien, T.R., C. Winkler, M. Dean, J.A.E. Nelson, M. Carrington, N.L. Michael, and G.C. White. 1997. HIV-1 infection in a man homozygous for CCR5Δ32. Lancet. 349:1219.
32. Theodorou, I., L. Meyer, M. Magierowska, C. Katlama, and C. Rouzioux. 1997. HIV-1 infection in an individual homozygous for CCR5Δ32. Lancet. 349: 1219-1220.
33. Michael, N.L., G. Chang, L.G. Louie, J.R. Mascola, D. Dondero, D.L. Birx, and H.W. Sheppard, 1997. The role of viral phenotype and CCR5-5 gene defects in HIV-1 transmission and disease progression. Nat. Med. 3:338-340.
34. Eugen-Olsen, J., A.K.N. Iverson, P. Garred, U. Koppelhus, C. Pedersen, T.L. Benfield, and A.M. Sorenson. 1997. Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals. AIDS (Lond.). 11:305-310.
35. Pantaleo, G., C. Graziosi, L. Butini, P.A. Pizzo, S.M. Schnittman, D.P. Kotler, and A.S. Fauci. 1991. Lymphoid organs function as major reservoirs for human immunodeficiency virus. Proc. Natl. Acad. Sci. USA. 88:9838-9842.
36. Cohen, O.J., G. Pantaleo, M. Holodniy, S. Schnittman, M. Niu, C. Graziosi, G.N. Pavlakis, J. Lalezari, J.A. Bartlett, R.T. Steigbigel, et al. 1995. Decreased HIV-1 plasma viremia during antiretroviral therapy reflects down-regulation of viral replication in lymphoid tissue. Proc. Natl. Acad. Sci. USA. 92:6017-6021.
37. Neumann, M., J. Harrison, M. Saltarelli, E. Hadziyannis, V. Erfle, B.K. Felber, and G.N. Pavlakis. 1994. Splicing variability in HIV type 1 revealed by quantitative RNA polymerase chain reaction. AIDS Res. Hum. Retroviruses. 10:1531-1542.
38. Fox, C.H., K. Tenner-Rácz, P. Rácz, A. Firpo, P.A. Pizzo, and A.S. Fauci. 1991. Lymphoid germinal centers are reservoirs of human immunodeficiency virus type 1 RNA. J. Infect. Dis. 164:1051-1057.
39. Wu, L., W.A. Paxton, N. Kassam, N. Ruffing, J.B. Rottman, N. Sullivan, H. Choe, J. Sodroski, W. Newman, R.A. Koup, and C.R. Mackay. 1997. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J. Exp. Med. 185:1681-1692.
40. Mellors, J.W., L.A. Kingsley, C.R. Rinaldo, Jr., J.A. Todd, B.S. Hoo, R.P. Kokka, and P. Gupta. 1995. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann. Intern. Med. 122:573-579.
41. Schacker, T., A.C. Collier, J. Hughes, T. Shea, and L. Corey. 1996. Clinical and epidemiologic features of primary HIV infection. Ann. Intern. Med. 125:257-264.
42. Balotta, C., P. Bagnarelli, C. Riva, A. Valenza, S. Antinori, M.C. Colombo, R. Sampaolesi, M. Violin, M.P. De Pasquale, M. Moroni, et al. 1997. Comparable biological and molecular determinants in HIV type 1-infected long term nonprogressors and recently infected individuals. AIDS Res. Hum. Retroviruses. 13:337-341.
43. Kaslow, R.A., R. Duquesnoy, M. VanRaden, L. Kingsley, M. Marrari, H. Friedman, S. Su, A.J. Saah, R. Detels, J. Phair, and C. Rinaldo. 1990. A1, Cw7, B8, DR3 HLA antigen combination associated with rapid decline of T-helper lymphocytes in HIV-1 infection. Lancet. 335:927-930.
44. Klein, M.R., I.P.M. Keet, J. D'Amaro, R.J. Bende, A. Hekman, B. Mesman, M. Koot, L.P. de Waal, R.A. Coutinho, and F. Miedema. 1994. Associations between HLA frequencies and pathogenic features of human immunodeficiency virus type 1 infection in seroconverters from the Amsterdam cohort of homosexual men. J. Infect. Dis. 169:1244-1249.
45. Kroner, B.L., J.J. Goedert, M. Carrington, D.L. Mann, and W.A. Blattner. 1995. Concordance of haplotype sharing, CD4 decline, and AIDS in hemophilic sibling pairs. AIDS. 9:275-280.
46. Kaslow, R.A., M. Carrington, R. Apple, L. Park, A. Muñoz, A.J. Saah, J.J. Goedert, C. Winkler, S.J. O'Brien, C. Rinaldo, et al. 1996. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat. Med. 2:405-411.
47. Weatherall, D.J. 1996. Host genetics and infectious disease. Parasitology. 112:S23-S29.
48. Winchester, R. 1994. The molecular basis of susceptibility to rheumatoid arthritis. Adv. Immunol. 56:389-466.
49. Smith, G., L.A. Stanley, E. Sim, R.C. Strange, and C.R. Wolf. 1995. Metabolic polymorphisms and cancer susceptibility. Cancer Surv. 25:27-65.
50. Garred, P., H.O. Madsen, U. Balslev, B. Hofmann, C. Pedersen, J. Gerstoft, and A. Svejgaard. 1997. Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin. Lancet. 349: 236-240.
51. Loetscher, M., T. Geiser, T. O'Reilly, R. Zwahlen, M. Baggiolini, and B. Moser. 1994. Cloning of a human seven-transmembrane domain receptor. LESTR, that is highly expressed in leukocytes. J. Biol. Chem. 269:232-237.
52. Feng, Y., CC. Broder, P.E. Kennedy, and E.A. Berger. 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane domain. G-protein coupled receptor. Science (Wash. DC). 272:872-877.
53. Berson, J.F., D. Long, B.J. Doranz, J. Rucker, F.R. Jirik, and R.W. Doms. 1996. A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains. J. Virol. 70: 6288-6295.
54. Bleul, C., M. Farazan, H. Choe, C. Parolin, I. Clark-Lewis, J. Sodroski, and T.A. Springer. 1996. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature (Lond.). 382:829-833.
55. Oberlin, E., A. Amara, F. Bachelerie, C. Bessia, J.L. Virelizier, F. Arenzana-Seisdedos, O. Schwartz, J.M. Heard, I. Clark-Lewis, D.F. Legler, et al. 1996. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature (Lond). 382:833-835.
56. Harrer, T., E. Harrer, S.A. Kalams, P. Barbosa, A. Trocha, R.P. Johnson, T. Elbeik, M.B. Feinberg, S.P. Buchbinder, and B.D. Walker. 1996. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load. J. Immunol. 156:2616-2623.
57. Barker, T.D., D. Weissman, J.A. Daucher, K.M. Roche, and A.S. Fauci. 1996. Identification of multiple and distinct CD8+ T cell suppressor activities. J. Immunol. 156:4476-4483.
58. Moriuchi, H., M. Moriuchi, C. Combadiere, P.M. Murphy, and A.S. Fauci. 1996. CD8+ T cell derived soluble factor(s), but not β-chemokines RANTES, MIP-1α, and MIP-1β, suppress HIV-1 replication in monocyte/macrophages. Proc. Natl. Acad. Sci. USA. 93:15341-15345.
59. Pilgrim, A.K., G. Pantaleo, O.J. Cohen, L.M. Fink, J.Y. Zhou, J.T. Zhou, D.P. Bolognesi, A.S. Fauci, and D.C. Montefiori. 1997. Neutralizing antibody responses at various stages of infection with human immunodeficiency virus type 1. J. Infect. Dis. In press.
60. Pantaleo, G., C. Graziosi, J.F. Demarest, L. Butini, M. Montroni, C.H. Fox, J.M. Orenstein, D.P. Kotler, and A.S. Fauci. 1993. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature (Lond.). 362:355-358.
61. Embretson, J., M. Zupancic, J.L. Ribas, A. Burke, P. Rácz, K. Tenner-Rácz, and A.T. Haase. 1993. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature (Lond.). 362:359-362.